Self-reported cancer-related cognitive impairment is associated with perturbed neurotransmission pathways
- PMID: 39325169
- PMCID: PMC11785672
- DOI: 10.1007/s00702-024-02824-9
Self-reported cancer-related cognitive impairment is associated with perturbed neurotransmission pathways
Abstract
Background: Cancer-related cognitive impairment (CRCI) is reported by 45% of patients with cancer. Significant gaps in knowledge remain regarding the mechanisms that underlie CRCI.
Objectives: Using a data-driven approach, the study purpose was to evaluate for perturbed pathways associated with membership in the High versus the Low CRCI profiles.
Methods: Patients completed the Attentional Function Index six times over two cycles of chemotherapy. Using findings from a previous latent profile analysis, subgroups of patients with high versus low levels of CRCI were evaluated (i.e., High versus Low CRCI profiles). Gene expression was quantified using either ribonucleic (RNA)-sequencing or microarray analyses and pathway impact analyses were performed. Signaling pathways were defined using the Kyoto Encyclopedia of Genes and Genomes database.
Results: A total of 508 patients had data available for analysis. Of the 261 patients in the RNA-sequencing sample, 48.7% were in the High class and 51.3% were in the Low class. Of the 247 patients the microarray sample, 46.6% were in the High class and 53.4% were in the Low class. Pathway impact analyses identified seven perturbed pathways related to neurotransmission (i.e., glutamatergic synapse, GABAergic synapse, dopaminergic synapse, serotonergic synapse, long-term depression, cholinergic synapse, retrograde endocannabinoid signaling).
Conclusions: This study is the first to describe associations between self-reported CRCI in patients receiving chemotherapy for breast, gastrointestinal, gynecological, or lung cancer and seven neurotransmission pathways. These findings provide new insights into potential targets for mechanistically based interventions.
Keywords: Cancer; Chemotherapy-related cognitive impairment; Cognition; Gene expression; Neurotransmission; Pathway analysis; Patient-reported outcomes.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare that they have no conflicts of interest. Ethical approval: This study adhered to the principles of the Declaration of Helsinki. The study was approved by the Institutional Review Board at the University of California, San Francisco and at each of the study sites. Consent: All of the patients signed written informed consent.
Similar articles
-
Neurodegenerative disease pathways are perturbed in patients with cancer who self-report cognitive changes and anxiety: A pathway impact analysis.Cancer. 2024 Aug 15;130(16):2834-2847. doi: 10.1002/cncr.35336. Epub 2024 Apr 27. Cancer. 2024. PMID: 38676932
-
Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways.Cytokine. 2021 Dec;148:155653. doi: 10.1016/j.cyto.2021.155653. Epub 2021 Aug 10. Cytokine. 2021. PMID: 34388477 Free PMC article.
-
Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment.Support Care Cancer. 2025 Mar 6;33(4):254. doi: 10.1007/s00520-025-09317-9. Support Care Cancer. 2025. PMID: 40047999 Free PMC article.
-
Chemotherapy-related cognitive impairment in older patients with cancer.J Geriatr Oncol. 2016 Jul;7(4):270-80. doi: 10.1016/j.jgo.2016.04.008. Epub 2016 Jul 5. J Geriatr Oncol. 2016. PMID: 27197918 Free PMC article. Review.
-
Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer.Breast Cancer Res Treat. 2023 Aug;201(1):15-26. doi: 10.1007/s10549-023-07005-y. Epub 2023 Jun 17. Breast Cancer Res Treat. 2023. PMID: 37329458 Review.
References
-
- Alhowail AH, Bloemer J, Majrashi M, Pinky PD, Bhattacharya S, Yongli Z, Bhattacharya D, Eggert M, Woodie L, Buabeid MA, Johnson N, Broadwater A, Smith B, Dhanasekaran M, Arnold RD, Suppiramaniam V (2019) Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidation. Toxicol Mech Methods 29(6):457–466. 10.1080/15376516.2019.1600086 - PubMed
-
- Aoki-Kinoshita KF, Kanehisa M (2007) Gene annotation and pathway mapping in KEGG. Methods in molecular biology. (Clifton NJ 396:71–91 doi:1-59745-515-6:71 - PubMed
-
- Atallah M, Cooper B, Munoz RF, Paul SM, Anguera J, Levine JD, Hammer M, Wright F, Chen LM, Melisko M, Conley YP, Miaskowski C, Dunn LB (2020) Psychological symptoms and stress are associated with decrements in attentional function in cancer patients undergoing chemotherapy. Cancer Nurs 43(5):402–410. 10.1097/NCC.0000000000000713 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical